Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity

BACKGROUND: Anti-vascular endothelial growth factor (Anti-VEGF) therapy is now considered as one of standard therapies in approaching infants with retinopathy of prematurity (ROP). The purpose of this study was to assess the time to full retinal vascularization in infants with ROP who were treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirghorbani, Masoud, Rashidinia, Ali, Yaseri, Mehdi, Zarei, Mohammad, Khojasteh, Hassan, Bazvand, Fatemeh, Modjtahedi, Bobeck S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864602/
https://www.ncbi.nlm.nih.gov/pubmed/35197117
http://dx.doi.org/10.1186/s40942-022-00364-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864602/
https://www.ncbi.nlm.nih.gov/pubmed/35197117
http://dx.doi.org/10.1186/s40942-022-00364-6

Ejemplares similares